Aptamers

Aptamers are short, single-stranded DNA or RNA molecules that bind with high selectivity and affinity to a target of interest. They are highly versatile and are used as molecular tools in life science research, therapeutics or diagnostics.

Products
Background
Literature
Cat No Product Name / Activity
6556 Anti-human EGFR aptamer, Janelia Fluor® 646 conjugate
High affinity anti-human EGFR aptamer conjugated to Janelia Fluor® 646
6557 Anti-human ErbB2 aptamer, Janelia Fluor® 646 conjugate
Anti-human ErbB2 aptamer, Janelia Fluor® 646 conjugate
6103 CD133-A15, 5'-DY647
High affinity fluorescently tagged aptamer for CD133 (AC133 epitope)
6104 CD133-B19, 5'-DY647
High affinity fluorescently tagged aptamer for CD133 (extracellular domain epitope)
6102 Ep23, 5'-DY647
High affinity fluorescently tagged aptamer for EpCam

Aptamers are short, single-stranded DNA or RNA molecules that bind with high selectivity and affinity to a target of interest. The sequence of nucleic acids confers a unique 3D structure, owing to the tendency of these molecules to form helices and single-stranded loops, which contributes to the target selectivity. Aptamers are also known as "chemical antibodies" but have certain advantages over antibodies, being non-immunogenic, easy to produce, small in size and chemically stable. In addition, since they are chemically synthesized they can be readily modified to improve pharmacokinetics or by addition of a fluorophore or photolabile group. They are highly versatile and are used as tools in life science research, to probe the function of cell surface molecules and sense or modulate cell surface interactions.

Aptamers are selected by a process known as Systematic Evolution of Ligands by EXponential enrichment (SELEX), first described by Tuerk and Gold in 1990. This in vitro procedure involves the incubation of a library of synthetic ssDNA and RNA with the target of choice. The target bound sequences are then separated out and amplified using PCR. This process is then repeated several times until a library enriched for target specific sequences is obtained, which is then cloned and sequenced to identify the individual monoclonal aptamers. This SELEX strategy is most commonly applied to proteins, but can be used across a wide range of targets including, small molecules, live cells, tissues and microorganisms. More recently the use of whole living cells as complex targets (known as cell-SELEX) has been described (Morris et al., 1998), which has the advantage of enabling the selection of aptamers under physiological conditions.

Aptamers have also been developed for medical use as therapeutics and diagnostics.

Literature for Aptamers

Tocris offers the following scientific literature for Aptamers to showcase our products. We invite you to request* or download your copy today!

*Please note that Tocris will only send literature to established scientific business / institute addresses.


Cancer

Cancer Research Product Guide

A collection of over 750 products for cancer research, the guide includes research tools for the study of:

  • Cancer Metabolism
  • Epigenetics in Cancer
  • Receptor Signaling
  • Cell Cycle and DNA Damage Repair
  • Angiogenesis
  • Invasion and Metastasis
Stem Cells

Stem Cells Scientific Review

Written by Kirsty E. Clarke, Victoria B. Christie, Andy Whiting and Stefan A. Przyborski, this review provides an overview of the use of small molecules in the control of stem cell growth and differentiation. Key signaling pathways are highlighted, and the regulation of ES cell self-renewal and somatic cell reprogramming is discussed. Compounds available from Tocris are listed.

Stem Cells

Stem Cells Poster

Written by Rebecca Quelch and Stefan Przyborski from Durham University (UK), this poster describes the isolation of pluripotent stem cells, their maintenance in culture, differentiation, and the generation and potential uses of organoids.